Dr. Joshua Seth Goldfaden is a Pittsburgh, Pennsylvania based Dentist who is specialized in Dentistry. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Joshua Seth Goldfaden is DS044329 for Dentistry in Pennsylvania. His current practice location is 3501 Terrace St, Salk Hall, G-132, Pittsburgh. Patients can reach him at 412-648-8616.
Dr. Joshua Seth Goldfaden is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Joshua Seth Goldfaden speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1992487862
NPI Enumeration Date:
01 Aug, 2023
NPI Last Update On:
04 Jun, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Joshua Seth Goldfaden are as mentioned below.
License Number
Specialization
State
Status
DS044329
Dentistry
Pennsylvania
Primary
109032
Dentistry
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3501 Terrace St Ste 3189, Pittsburgh, Pennsylvania
Zip:
15213-2523
Phone Number:
412-648-8616
Patients can reach Dr. Joshua Seth Goldfaden at 3501 Terrace St, Salk Hall, G-132, Pittsburgh, Pennsylvania or can call to book an appointment on 412-648-8616. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.